Figure 2.

Optimal treatment type and timing varies by patient phenotype. Treatment score (see methods) for six distinct patient phenotypes. Each treatment is tested with initiation at each of the first 14 days following viral exposure. A score of 1.0 (shown by dashed vertical line) indicates treatment resulted in a patient status midway between day 20 and baseline (day 1). A score of less than one indicates treatment resulted in patient status being closer to untreated day 20 than day 1, while a score of greater than one indicates treatment moved the patient closer to baseline by day 20.